-The Hindu India’s IPR regime, never in the background, has come under sharp focus recently for a variety of reasons. It is ten years since India amended the Indian Patents Act, 1970 to bring its laws in line with the agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). The most important of those amendments related to the introduction of product patents for 20 years, including for pharmaceutical products. Significant safeguards were...

-The Hindu It was resolved that all IMA members shall write drugs with chemical or generic name in capital letters A resolution was passed at the recent working committee meeting of the Indian Medical Association (IMA) that is likely to have the direct benefit of making drugs more accessible and affordable. It was resolved that all IMA members “shall write drugs with chemical or generic name in capital letters, and the name of...

-The Hindu The failure of successive governments in India, especially those in States that have the highest mortality rates among children younger than five years, to address the critical issue of training health-care providers in rural areas to correctly diagnose and treat children suffering from diarrhoea and pneumonia, has had tragic consequences. These ailments account for the maximum number of under-5 mortality incidence in the country. That the poor management...

-The Hindu Chennai: The reason why a large number of children under the age of five years die of diarrhoea and pneumonia, generally in rural India and especially in Bihar, has become clear. Diarrhoea and pneumonia are the biggest killer diseases in children in India. With 55 per 1,000 live births, Bihar has the highest infant mortality rate in the country. But 340 health care providers in rural Bihar rarely practice what...

-The Telegraph New Delhi: International health activists have joined their Indian counterparts in decrying what they say are Barack Obama's dual policy on big drug companies, pledging to break their stranglehold in the US but promoting their interests in India. The activists claimed yesterday that the India-US joint statement, issued during Obama's visit to India, contains signals that the Indian government could be preparing to weaken its intellectual property regulations on medicines,...